Advertisement

Topics

Arch Oncology, Inc. Company Profile

14:13 EDT 26th March 2019 | BioPortfolio

Arch Oncology, Inc. is a privately-held, clinical-stage immuno-oncology company focused on the discovery and development of best-in-class antibody therapies for the treatment of patients with cancer. The Company’s next-generation anti-CD47 antibodies are highly differentiated, with the potential to improve upon the safety and efficacy profile relative to other agents in this class. Arch’s lead therapy AO-176 is in a Phase 1 clinical trial for the treatment of patients with select solid tumors. Arch’s leadership team has successfully developed new drugs for patients before and is backed by leading investors, including RiverVest Venture Partners, Roche Venture Fund, and 3x5 Partners. For more information please visit www.archoncology.com.


News Articles [611 Associated News Articles listed on BioPortfolio]

Arch Oncology raises $50m Series B financing

The Company plans to use the proceeds from this financing to advance its anti-CD47 antibody AO-176’s ongoing Phase 1 clinical trial in select solid tumors, as well as The post Arch Oncology raises ...

Arch Oncology Announces First Patient Dosed in Phase 1 Clinical Trial of AO-176, an Anti-CD47 Antibody in patients with select solid tumors https://www.businesswire.com/news/home/20190206005055/en/Arch-Oncology-Announces-Patient-Dosed-Phase-1 …

Arch Oncology Announces First Patient Dosed in Phase 1 Clinical Trial of AO-176, an Anti-CD47 Antibody in patients with select solid tumors https://www.businesswire.com/news/home/20190206005055/en/Ar...

Arch Oncology Raises $50 Million Series B Financing

-- Financing to Advance Lead Anti-CD47 Antibody AO-176 in Ongoing Phase 1 Clinical Trial and Pipeline -- Arch Oncology, Inc., a clinical-stage immuno-oncology company focused ...

Arch Oncology raises $50M series B to develop anti-CD47 mAb

Arch Biopartners Provides Toxicology Update for Metablok

Arch Biopartners (TSXV:ARCH;OTCQB:ACHFF) today provided an update on the general results from toxicology and pharmacology studies evaluating Metablok, the Company’s lead drug candidate for treating ...

Third Rock And ARCH-Backed Genetics Startup Launches With Nearly $200 Million

Maze Therapeutics, a South San Francisco startup, launched with funding from Third Rock Ventures, ARCH Venture Partners, GV and others, with a goal of identifying genetic modifiers to develop new drug...

Arch Oncology Announces First Patient Dosed in Phase 1 Clinical Trial of AO-176, an Anti-CD47 Antibody with a Best-in-Class Profile

Phase 1 Clinical Trial to Evaluate AO-176 for the Treatment of Patients with Select Solid Tumors Arch Oncology, Inc., a clinical-stage immuno-oncology company focused on ...

Arch Oncology raises $50M in Series B round for Phase I CD47-targeting antibody

The company joins a small but growing list of firms developing drugs targeting CD47, the “don’t eat me” immune checkpoint. Another company, further ahead in development, is Forty Sev...

PubMed Articles [1458 Associated PubMed Articles listed on BioPortfolio]

Case Series of Aortic Arch Aneurysm in Patients with Bovine Arch Treated with Proximal Scalloped and Fenestrated Stent Graft.

The bovine arch is the most common variant of the aortic arch and occurs when the innominate artery shares a common origin with the left common carotid artery. We report an endovascular repair of aort...

Mid-term results of two-stage hybrid arch repair for extensive aortic arch aneurysms.

This report evaluated the perioperative and mid-term results of the two-stage hybrid arch procedure. This procedure involves total arch replacement with an elephant trunk as the first stage and thorac...

Combined aortic arch resection for lung cancer using total rerouting of supra-arch vessels.

Surgery for aortic arch involvement in lung cancer cases is challenging, and generally requires extracorporeal circulation with circulatory arrest or a cerebral protection technique. To reduce morbidi...

Surgical Approach for Hypoplastic Mirror Circumflex Aortic Arch.

Surgical approach for mirror-form of circumflex aortic arch with a long-segment hypoplasia is described. Instead of "uncrossing" the arch, posterior aortic translocation aorta is required for the mirr...

Fenestrated Endovascular Repair of Zones 1 and 2 Aortic Arch Pathologies.

and Design: Surgical management of aortic arch pathologies is complex, and endovascular developments have now enabled total or hybrid endovascular aortic arch repair. We present our early experience w...

Clinical Trials [718 Associated Clinical Trials listed on BioPortfolio]

Identification of Patients With Age-Related Clonal Hematopoiesis (ARCH) Among Cancer Survivors

The purpose of this study is to see if patients with cancer have a certain amount of genetic mutations in their blood. If certain levels of mutations are found in specific genes, patients ...

Comparison of Arch Expansion Changes Between Passive Self-ligating and Conventional Brackets

The purpose of this randomized controlled clinical trial was to compare the transverse development of the arches and the incisor inclination comparing two different ligating systems (SL vs...

Aortic Arch Related Cerebral Hazard Trial (ARCH)

The ARCH is a controlled trial with a sequential design and with a prospective, randomized, open-label, blinded-endpoint (PROBE) methodology. The objective is to compare the efficacy and t...

A Prospective Randomized Clinical Trial to Compare Between Two Leveling and Alignment Protocols for the Treatment of Class II Division 2 Malocclusion

The aim of this prospective study was to compare between two different treatment modalities of class II division 2; to start treatment in upper arch first until adequate overjet is obtaine...

Evaluation and Classification of Foot Medial Longitudinal Arch Height in Adults

The aim of the study is, to evaluate and classificate the medial longitudinal arch height in adult individuals. Aged between 18-40 years,350 adults who are voluntarily participate is going...

Companies [786 Associated Companies listed on BioPortfolio]

Arch Oncology, Inc.

Arch Oncology, Inc. is a privately-held, clinical-stage immuno-oncology company focused on the discovery and development of best-in-class antibody therapies for the treatment of p...

Endospan

Privately held Endospan, headquartered in Herzlia (Tel Aviv), Israel, is a pioneer in the endovascular repair of Aortic Arch Disease including aneurysms and dissections. End...

Three Arch Partners

Three Arch Partners was formed in 1993 to provide young companies with access to relevant clinical and business resources, as well as capital. Three Arch has helped create, build and fund more than fi...

Arch Grants

Arch Grants creates an entrepreneurial culture and infrastructure to build successful companies in St. Louis. The organization provides $50,000 equity-free grants and pro bono sup...

ARCH Clinical Research

ARCH Clinical Research provides pharmaceutical and biotechnology companies with high-quality clinical research services in Australia and New Zealand. In a time- and cost-efficient manner and according...

More Information about "Arch Oncology, Inc." on BioPortfolio

We have published hundreds of Arch Oncology, Inc. news stories on BioPortfolio along with dozens of Arch Oncology, Inc. Clinical Trials and PubMed Articles about Arch Oncology, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Arch Oncology, Inc. Companies in our database. You can also find out about relevant Arch Oncology, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Antibodies
An antibody is a protein produced by the body's immune system when it detects harmful substances, called antigens. Examples of antigens include microorganisms (such as bacteria, fungi, parasites, and viruses) and chemicals. Antibodies may be produc...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...


Corporate Database Quicklinks



Searches Linking to this Company Record